Company news

Genexine, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Genexine’s GX-BP1 (SOX2 bioPROTAC) Suppresses Tumor Regrowth despite Osimertinib and Dato-DXd Combination and Achieves 6/6 Complete Responses in Triple Combination

September 15, 2026

Decks